Guardant Health
GH
#1043
Rank
S$29.30 B
Marketcap
S$218.35
Share price
-8.83%
Change (1 day)
166.33%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of June 2026 : S$1.34 Billion

According to Guardant Health 's latest financial reports the company has S$1.34 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$1.54 B35.12%
2024-12-31S$1.14 B-26.02%
2023-12-31S$1.54 B13.85%
2022-12-31S$1.35 B7.51%
2021-12-31S$1.26 B-46.89%
2020-12-31S$2.37 B236.89%
2019-12-31S$0.70 B23.14%
2018-12-31S$0.57 B93.36%
2017-12-31S$0.29 B114.72%
2016-12-31S$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Neogen
NEOG
S$0.23 B-82.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S$1.39 B 3.61%๐Ÿ‡บ๐Ÿ‡ธ USA